News

Check all IrsiCaixa scientific news in just one click.

SARS-CoV-2

Therapies

16/02/2022

Key to plitidepsin's success, preventing SARS-CoV-2 replication inside cells

SARS-CoV-2

Vaccines

19/01/2022

The European RBDCOV project will study HIPRA’s COVID-19 vaccine in children, adolescents and immunocompromised patients

SARS-CoV-2

Therapies

22/12/2021

Study shows efficacy of remdesivir in preventing severity of COVID-19 and European Commission extends its use in people at risk

20/12/2021

IrsiCaixa and Vall d’Hebron map the HIV reservoir and describe the atlas of cells where the virus is hidden

30/11/2021

Use of PrEP in Catalonia could save 93 million euros over the next 40 years

21/11/2021

Barcelona CaixaResearch Living Lab, promoting impact research with and for society

whatsapp_image_2021-11-22_at_12.32.36.jpeg

21/11/2021

More than 20 organisations collaborate as a network to improve the model for promoting healthy and sustainable food in Barcelona

07/10/2021

IrsiCaixa is working on the development of synthetic antibodies to prevent SARS-CoV-2 infection thanks to the support of the Gloria Soler Foundation

28/09/2021

Two IrsiCaixa researchers will be part of the Scientific Advisory Committee of COVID-19 of the Department of Health